<p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）在周三发布给客户和投资者的研究报告中，被巴克莱的股票分析师从 “持平” 评级上调至 “增持” 评级，MarketBeat.com 报道称。该券商目前对该股票的目标价格为 35.00 美元。巴克莱的价格目标指向该股票从之前收盘价潜在上涨 28.90%。</p>
<ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
<p>其他分析师也对该公司发布了报告。Weiss Ratings 在 4 月 21 日的研究报告中重申了对 Oscar Health 股票的 “卖出（d）” 评级。Raymond James Financial 将 Oscar Health 的评级从 “市场表现” 上调至 “跑赢大盘”，并在 2 月 12 日的研究报告中设定了 18.00 美元的价格目标。瑞银集团在 5 月 7 日的报告中将 Oscar Health 的价格目标从 15.00 美元上调至 20.00 美元，并给予该公司 “中性” 评级。Zacks Research 在 6 月 5 日的研究报告中将 Oscar Health 的评级从 “强力买入” 下调至 “持有”。最后，Wolfe Research 在 5 月 5 日的报告中开始覆盖 Oscar Health，并对该股票给予 “同行表现” 评级。三位研究分析师对该股票给予了买入评级，八位分析师给予了持有评级，一位分析师给予了卖出评级。根据 MarketBeat 的数据，Oscar Health 的共识评级为 “持有”，平均价格目标为 20.78 美元。</p>
<p><strong>查看我们关于 OSCR 的最新报告</strong></p>
<h2>Oscar Health 股票下跌 0.9%</h2>
<p>Oscar Health 股票在周三开盘价为 27.15 美元。该公司的市值为 81.9 亿美元，市盈率为-46.02，市盈增长比率为 1.92，贝塔值为 2.37。Oscar Health 的 12 个月低点为 10.69 美元，12 个月高点为 28.16 美元。该公司的 50 日移动平均线为 19.02 美元，200 日移动平均线为 16.25 美元。该公司的速动比率为 1.11，流动比率为 1.11，债务与股本比率为 0.26。</p>
<p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）在 5 月 6 日最后发布了季度财报。该公司报告季度每股收益为 2.07 美元，超出分析师共识预期的 1.11 美元，超出幅度为 0.96 美元。Oscar Health 的净利润率为-0.30%，股本回报率为-3.26%。该公司在季度内的收入为 46.5 亿美元，而分析师预期为 49 亿美元。去年同期，该公司每股收益为 0.92 美元。该公司的季度收入同比增长 52.6%。作为一个整体，卖方分析师预测 Oscar Health 在当前财政年度将发布 0.47 美元的每股收益。</p>
<h2>内部人士下注</h2>
<p>在相关消息中，首席执行官 Mark T. Bertolini 在 4 月 6 日的交易中购买了 1,000,000 股公司的股票。每股购买价格为 11.92 美元，总交易额为 11,920,000.00 美元。收购完成后，首席执行官直接持有公司 10,196,876 股股票，价值 121,546,761.92 美元。这笔交易代表了他们持股比例的 10.87% 的增加。该收购在与 SEC 的法律文件中披露，可以通过此链接访问。此外，内部人士 Adam Mcananey 在 6 月 2 日的交易中出售了 9,859 股 Oscar Health 股票。每股出售价格为 21.94 美元，总价值为 216,306.46 美元。交易后，该内部人士直接持有 218,096 股公司股票，价值约为 4,785,026.24 美元。这笔交易是他们持股比例的 4.32% 的减少。该出售的披露在 SEC 文件中可用。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税收扣缴义务。在过去 90 天内，内部人士已出售价值 4,283,140 美元的 189,660 股公司股票。公司内部人士持有公司 25.11% 的股票。</p>
<h2>对 Oscar Health 的对冲基金看法</h2>
<p>一些对冲基金最近买入和卖出了该公司的股票。BIT Capital GmbH 在第四季度将其在 Oscar Health 的股份增加了 545.0%。BIT Capital GmbH 现在拥有 6,186,267 股公司股票，价值 88,897,000 美元，在上个季度又收购了 5,227,152 股。American Century Companies Inc.在第三季度将其在 Oscar Health 的持股增加了 89.0%。American Century Companies Inc.现在拥有 5,298,340 股公司股票，价值 100,298,000 美元，在上个季度又购买了 2,495,691 股。Farallon Capital Management LLC 在第三季度将其在 Oscar Health 的持股增加了 146.5%。Farallon Capital Management LLC 现在拥有 3,639,000 股公司股票，价值 68,886,000 美元，在上个季度又购买了 2,163,000 股。摩根士丹利在第四季度将其在 Oscar Health 的持股增加了 42.8%。摩根士丹利现在拥有 6,814,046 股公司股票，价值 97,918,000 美元，在上个季度又购买了 2,043,758 股。最后，美国银行在第一季度将其在 Oscar Health 的持股增加了 205.1%。美国银行现在拥有 2,860,310 股公司股票，价值 32,808,000 美元，在上个季度又购买了 1,922,732 股。75.70% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>关于 Oscar Health</h2>
<p>（获取免费报告）</p>
<p>Oscar Health，作为纽约证券交易所上市公司，股票代码为 OSCR，是一家总部位于纽约的科技驱动健康保险公司。该公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 于 2012 年创立，旨在简化医疗保险覆盖并提升会员体验。Oscar 利用其专有的数字平台来简化计划注册、索赔管理和会员支持，在个人、家庭和小型团体保险市场中脱颖而出。</p>
<p>公司的主要产品包括根据《平价医疗法案》提供的交易所内个人和家庭医疗计划、交易所外计划以及医疗保险优势产品。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比 Oscar Health 更好</li>
<li>光纤电缆公司：强劲的收益，但仍面临障碍</li>
<li>父母银行正在蓬勃发展——3 只值得关注的股票</li>
<li>康宁正在用玻璃铺就人工智能的未来</li>
<li>为什么亚马逊突然落后于标准普尔 500 指数，这是否是一个警告？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Oscar Health 吗？</h2>
<p>在考虑 Oscar Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Oscar Health 并不在名单上。</p>
<p>虽然 Oscar Health 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

OSCR

OSCG

OSCX

<p>巴克莱将 Oscar Health（纽约证券交易所代码：OSCR）的评级上调至 “增持”，目标价为 35 美元，理由是其潜在的上涨空间。其他分析师如雷蒙德·詹姆斯和瑞银也调整了评级或目标价。首席执行官马克·贝托利尼最近购买了 100 万股，而内部人士亚当·麦克纳尼则出售了一些股份。对冲基金 BIT Capital GmbH 和 American Century Companies 在最近几个季度显著增加了其持股</p>

<p>Oscar Health (NYSE:OSCR - Get Free Report) was upgraded by stock analysts at Barclays from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating in a research report issued to clients and investors on Wednesday, MarketBeat.com reports. The brokerage currently has a $35.00 target price on the stock. Barclays's price objective points to a potential upside of 28.90% from the stock's previous close.</p>
<div class="lb-trans"><p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）在周三发布给客户和投资者的研究报告中，被巴克莱的股票分析师从 “持平” 评级上调至 “增持” 评级，MarketBeat.com 报道称。该券商目前对该股票的目标价格为 35.00 美元。巴克莱的价格目标指向该股票从之前收盘价潜在上涨 28.90%。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
</div><p>Other analysts have also issued reports about the company. Weiss Ratings reaffirmed a &#34;sell (d)&#34; rating on shares of Oscar Health in a research report on Tuesday, April 21st. Raymond James Financial raised Oscar Health from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $18.00 price objective for the company in a research note on Thursday, February 12th. UBS Group boosted their price objective on Oscar Health from $15.00 to $20.00 and gave the company a &#34;neutral&#34; rating in a report on Thursday, May 7th. Zacks Research lowered Oscar Health from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Friday, June 5th. Finally, Wolfe Research assumed coverage on Oscar Health in a report on Tuesday, May 5th. They issued a &#34;peer perform&#34; rating on the stock. Three research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Oscar Health has a consensus rating of &#34;Hold&#34; and an average price target of $20.78.</p>
<div class="lb-trans"><p>其他分析师也对该公司发布了报告。Weiss Ratings 在 4 月 21 日的研究报告中重申了对 Oscar Health 股票的 “卖出（d）” 评级。Raymond James Financial 将 Oscar Health 的评级从 “市场表现” 上调至 “跑赢大盘”，并在 2 月 12 日的研究报告中设定了 18.00 美元的价格目标。瑞银集团在 5 月 7 日的报告中将 Oscar Health 的价格目标从 15.00 美元上调至 20.00 美元，并给予该公司 “中性” 评级。Zacks Research 在 6 月 5 日的研究报告中将 Oscar Health 的评级从 “强力买入” 下调至 “持有”。最后，Wolfe Research 在 5 月 5 日的报告中开始覆盖 Oscar Health，并对该股票给予 “同行表现” 评级。三位研究分析师对该股票给予了买入评级，八位分析师给予了持有评级，一位分析师给予了卖出评级。根据 MarketBeat 的数据，Oscar Health 的共识评级为 “持有”，平均价格目标为 20.78 美元。</p>
</div><p><strong>View Our Latest Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 OSCR 的最新报告</strong></p>
</div><h2>Oscar Health Stock Down 0.9%</h2>
<div class="lb-trans"><h2>Oscar Health 股票下跌 0.9%</h2>
</div><p>Oscar Health stock opened at $27.15 on Wednesday. The company has a market capitalization of $8.19 billion, a PE ratio of -46.02, a PEG ratio of 1.92 and a beta of 2.37. Oscar Health has a 12-month low of $10.69 and a 12-month high of $28.16. The firm's fifty day moving average is $19.02 and its 200 day moving average is $16.25. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26.</p>
<div class="lb-trans"><p>Oscar Health 股票在周三开盘价为 27.15 美元。该公司的市值为 81.9 亿美元，市盈率为-46.02，市盈增长比率为 1.92，贝塔值为 2.37。Oscar Health 的 12 个月低点为 10.69 美元，12 个月高点为 28.16 美元。该公司的 50 日移动平均线为 19.02 美元，200 日移动平均线为 16.25 美元。该公司的速动比率为 1.11，流动比率为 1.11，债务与股本比率为 0.26。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business had revenue of $4.65 billion during the quarter, compared to analysts' expectations of $4.90 billion. During the same period last year, the company posted $0.92 earnings per share. The business's quarterly revenue was up 52.6% on a year-over-year basis. As a group, sell-side analysts predict that Oscar Health will post 0.47 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）在 5 月 6 日最后发布了季度财报。该公司报告季度每股收益为 2.07 美元，超出分析师共识预期的 1.11 美元，超出幅度为 0.96 美元。Oscar Health 的净利润率为-0.30%，股本回报率为-3.26%。该公司在季度内的收入为 46.5 亿美元，而分析师预期为 49 亿美元。去年同期，该公司每股收益为 0.92 美元。该公司的季度收入同比增长 52.6%。作为一个整体，卖方分析师预测 Oscar Health 在当前财政年度将发布 0.47 美元的每股收益。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In related news, CEO Mark T. Bertolini bought 1,000,000 shares of the company's stock in a transaction dated Monday, April 6th. The shares were bought at an average price of $11.92 per share, for a total transaction of $11,920,000.00. Following the completion of the acquisition, the chief executive officer directly owned 10,196,876 shares of the company's stock, valued at $121,546,761.92. This trade represents a 10.87% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Adam Mcananey sold 9,859 shares of Oscar Health stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $216,306.46. Following the transaction, the insider directly owned 218,096 shares in the company, valued at approximately $4,785,026.24. The trade was a 4.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 189,660 shares of company stock worth $4,283,140 in the last 90 days. Company insiders own 25.11% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，首席执行官 Mark T. Bertolini 在 4 月 6 日的交易中购买了 1,000,000 股公司的股票。每股购买价格为 11.92 美元，总交易额为 11,920,000.00 美元。收购完成后，首席执行官直接持有公司 10,196,876 股股票，价值 121,546,761.92 美元。这笔交易代表了他们持股比例的 10.87% 的增加。该收购在与 SEC 的法律文件中披露，可以通过此链接访问。此外，内部人士 Adam Mcananey 在 6 月 2 日的交易中出售了 9,859 股 Oscar Health 股票。每股出售价格为 21.94 美元，总价值为 216,306.46 美元。交易后，该内部人士直接持有 218,096 股公司股票，价值约为 4,785,026.24 美元。这笔交易是他们持股比例的 4.32% 的减少。该出售的披露在 SEC 文件中可用。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税收扣缴义务。在过去 90 天内，内部人士已出售价值 4,283,140 美元的 189,660 股公司股票。公司内部人士持有公司 25.11% 的股票。</p>
</div><h2>Hedge Funds Weigh In On Oscar Health</h2>
<div class="lb-trans"><h2>对 Oscar Health 的对冲基金看法</h2>
</div><p>A number of hedge funds have recently bought and sold shares of the company. BIT Capital GmbH grew its stake in shares of Oscar Health by 545.0% in the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company's stock worth $88,897,000 after acquiring an additional 5,227,152 shares in the last quarter. American Century Companies Inc. lifted its position in shares of Oscar Health by 89.0% during the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock valued at $100,298,000 after purchasing an additional 2,495,691 shares in the last quarter. Farallon Capital Management LLC boosted its holdings in Oscar Health by 146.5% during the third quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company's stock worth $68,886,000 after purchasing an additional 2,163,000 shares during the last quarter. Morgan Stanley boosted its holdings in Oscar Health by 42.8% during the fourth quarter. Morgan Stanley now owns 6,814,046 shares of the company's stock worth $97,918,000 after purchasing an additional 2,043,758 shares during the last quarter. Finally, Bank of America Corp DE grew its position in Oscar Health by 205.1% in the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company's stock worth $32,808,000 after purchasing an additional 1,922,732 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些对冲基金最近买入和卖出了该公司的股票。BIT Capital GmbH 在第四季度将其在 Oscar Health 的股份增加了 545.0%。BIT Capital GmbH 现在拥有 6,186,267 股公司股票，价值 88,897,000 美元，在上个季度又收购了 5,227,152 股。American Century Companies Inc.在第三季度将其在 Oscar Health 的持股增加了 89.0%。American Century Companies Inc.现在拥有 5,298,340 股公司股票，价值 100,298,000 美元，在上个季度又购买了 2,495,691 股。Farallon Capital Management LLC 在第三季度将其在 Oscar Health 的持股增加了 146.5%。Farallon Capital Management LLC 现在拥有 3,639,000 股公司股票，价值 68,886,000 美元，在上个季度又购买了 2,163,000 股。摩根士丹利在第四季度将其在 Oscar Health 的持股增加了 42.8%。摩根士丹利现在拥有 6,814,046 股公司股票，价值 97,918,000 美元，在上个季度又购买了 2,043,758 股。最后，美国银行在第一季度将其在 Oscar Health 的持股增加了 205.1%。美国银行现在拥有 2,860,310 股公司股票，价值 32,808,000 美元，在上个季度又购买了 1,922,732 股。75.70% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>About Oscar Health</h2>
<div class="lb-trans"><h2>关于 Oscar Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.</p>
<div class="lb-trans"><p>Oscar Health，作为纽约证券交易所上市公司，股票代码为 OSCR，是一家总部位于纽约的科技驱动健康保险公司。该公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 于 2012 年创立，旨在简化医疗保险覆盖并提升会员体验。Oscar 利用其专有的数字平台来简化计划注册、索赔管理和会员支持，在个人、家庭和小型团体保险市场中脱颖而出。</p>
</div><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p>
<div class="lb-trans"><p>公司的主要产品包括根据《平价医疗法案》提供的交易所内个人和家庭医疗计划、交易所外计划以及医疗保险优势产品。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>Optical Cable Corporation: Strong Earnings, But Hurdles Remain</li>
<li>The Bank of Mom and Dad Is Booming—3 Stocks to Watch</li>
<li>Corning Is Paving AI's Future With Glass</li>
<li>Why's Amazon Suddenly Lagging the S&amp;P 500, and Is It a Warning?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Oscar Health 更好</li>
<li>光纤电缆公司：强劲的收益，但仍面临障碍</li>
<li>父母银行正在蓬勃发展——3 只值得关注的股票</li>
<li>康宁正在用玻璃铺就人工智能的未来</li>
<li>为什么亚马逊突然落后于标准普尔 500 指数，这是否是一个警告？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=OSCR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Oscar Health 吗？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Oscar Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Oscar Health 并不在名单上。</p>
</div><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Oscar Health 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Oscar Health（NYSE:OSCR）在巴克莱被上调至 “增持” 评级